Clinical epidemiology of heart failure: public and private health burden

Area of Science:

• Cardiology
• Public Health
• Preventive Medicine

Background:

• Clinically overt heart failure (HF) presents a significant public health challenge, characterized by high morbidity, mortality, and healthcare costs.
• Despite the proven benefits of angiotensin-converting enzyme inhibitors, HF remains a leading cause of disability and death.
• The progression from asymptomatic left ventricular dysfunction to overt HF results in a dramatic decline in quality of life and prognosis.

Purpose of the Study:

• To emphasize the need for enhanced strategies in managing heart failure.
• To highlight the limitations of current treatments in fully addressing the heart failure epidemic.
• To advocate for a proactive approach involving screening and prevention to mitigate the impact of heart failure.

Main Methods:

• This study is a conceptual analysis and review of existing literature on heart failure management and prevention.
• It synthesizes evidence on the progression of heart failure and its associated economic and clinical burdens.
• The analysis focuses on the potential impact of early detection and preventive interventions.

Main Results:

• Current treatments, while beneficial, are insufficient to overcome the widespread burden of heart failure.
• The transition to overt heart failure signifies a critical point of irreversible decline.
• Screening and prevention programs are identified as potentially effective strategies.

Conclusions:

• A comprehensive program of screening and prevention is necessary to effectively reduce the public health burden of heart failure.
• Implementing such a program is likely to be cost-effective, considering the economic consequences of overt heart failure.
• Early intervention is key to improving long-term outcomes and reducing the societal impact of heart failure.